Eterna Therapeutics Inc (ERNA) support and resistance · P/E 0.0, rev $582.0K
Eterna Therapeutics Inc (ERNA) is a biotechnology company listed on NASDAQ.
This page maps Eterna Therapeutics Inc (ERNA) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported ERNA revenue for 2024-12-31 was $582.0K. Net income was -$44.5M. Revenue was up 755.9% from 2023-12-31 to 2024-12-31. ERNA currently screens at market cap $6.9M and trailing P/E 0.0.
ERNA currently screens at market cap $6.9M and trailing P/E 0.0. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new ERNA 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the ERNA quote page for the session range and the stock page for the full model.
Not investment advice.